Just looking ahead to March: it seems to me that HGSI's Benlysta—the first new systemic lupus drug in 50 years—will get FDA approval on March 10. I'm considering buying next week, but what worries me is the already high PPS, $25+, and just how much approval pop it can get from that level. Any thoughts much appreciated, TIA.